Robot-Assisted Rehabilitation Treadmills Market Report 2026

The robot-assisted rehabilitation treadmills market size has grown rapidly in recent years. It will grow from $0.97 billion in 2025 to $1.09 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to increasing adoption of robotic rehabilitation devices, growing prevalence of neurological disorders, rising demand for advanced physiotherapy solutions, expansion of rehabilitation centers, increasing focus on patient mobility restoration.

The robot-assisted rehabilitation treadmills market size is expected to see rapid growth in the next few years. It will grow to $1.72 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to growing investment in medical robotics, increasing demand for technology-assisted rehabilitation, rising focus on personalized therapy solutions, expansion of outpatient rehabilitation services, growing elderly population requiring mobility support and Major trends in the forecast period include technology advancements in robotic gait training systems, innovations in sensor-integrated rehabilitation treadmills, developments in artificial intelligence-assisted rehabilitation, research and development in neurorehabilitation robotics, advancements in immersive rehabilitation technologies.

The rising prevalence of neurological disorders is expected to drive the growth of the robot-assisted rehabilitation treadmills market in the coming years. Neurological disorders are conditions that affect the brain, spinal cord, or nerves, disrupting normal nervous system function and causing impairments in movement, cognition, sensation, behavior, or overall bodily control. Their increasing prevalence is linked to unhealthy lifestyle habits, including poor diet, physical inactivity, smoking, excessive alcohol consumption, and chronic stress. Robot-assisted rehabilitation treadmills support neurological disorder management by providing guided, repetitive gait training with real-time feedback and adaptive support. They enhance patient outcomes by improving mobility, muscle strength, balance, and functional recovery during rehabilitation. For example, in June 2025, Brain Research UK, a United Kingdom-based neurological charity, reported that the prevalence of neurological conditions rose from 10.5 million people in 2024 to an estimated 11 million in 2025, a 4.8 % increase year over year. Consequently, the growing demand for targeted rehabilitation solutions is fueling the expansion of the robot-assisted rehabilitation treadmills market.

Major companies in the robot-assisted rehabilitation treadmills market are focusing on developing advanced products, such as anti-gravity body weight support systems, to enhance patient mobility outcomes, accelerate recovery, and improve clinical rehabilitation protocols. Anti-gravity body weight support systems are integrated mechanisms that reduce a patient’s effective body weight during treadmill walking, allowing individuals with mobility impairments to participate in gait training with reduced risk of falls and less physical strain. For example, in June 2024, ReWalk Robotics Ltd., an Israel-based provider of rehabilitation technology solutions, introduced the AlterG NEO Anti-Gravity Treadmill. This cost-effective, user-friendly treadmill features the company’s patented Differential Air Pressure (DAP) technology, which delivers precise and consistent unweighting, enabling safe rehabilitation and athletic training while reducing stress on injured joints and muscles. Its updated design and accessible price point aim to make the benefits of anti-gravity therapy available to a wider range of physical rehabilitation clinics and athletic training facilities.

In August 2023, ReWalk Robotics Ltd., an Israel-based provider of robotic mobility and neurorehabilitation solutions, acquired AlterG Inc. for approximately $19 million. Through this acquisition, ReWalk aims to expand its rehabilitation technology portfolio by incorporating AlterG’s anti-gravity treadmill systems, which are used globally in physical and neurological rehabilitation, thereby strengthening its offerings in robot-assisted rehabilitation treadmills and extending its market presence in both clinic and home-based gait training solutions. AlterG Inc. is a US-based developer and manufacturer of anti-gravity treadmill systems that utilize patented Differential Air Pressure technology to support mobility recovery and reduce the effects of gravity in robot-assisted rehabilitation.

Major companies operating in the robot-assisted rehabilitation treadmills market are HIWIN Corp., Biodex Medical Systems Inc., Reha Technology AG, Guangzhou Longest Science & Technology Co. Ltd., Hocoma AG, Motek Medical B.V., Ekso Bionics Holdings Inc., Tyromotion GmbH, ReWalk Robotics Ltd., Meditouch Ltd., Woodway USA Inc., Restorative Therapies Inc., BAMA Teknoloji A.Ş., Aretech LLC, Bionik Laboratories Corp., Techno Concept Inc., Rex Bionics Plc, Rehab‑Robotics Company Limited, LokoHelp Group GmbH, ZARYA.

North America was the largest region in the robot-assisted rehabilitation treadmills market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted rehabilitation treadmills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robot-assisted rehabilitation treadmills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the robot-assisted rehabilitation treadmills market by increasing costs of imported motors, sensors, robotic actuators, control systems, and precision mechanical components. rehabilitation centers and hospitals in north america and europe are most affected due to reliance on imported robotic subsystems, while asia-pacific faces cost pressures on system manufacturing and exports. these tariffs are increasing equipment acquisition costs and extending purchasing cycles. however, they are also encouraging local assembly, regional component sourcing, and innovation in modular and cost-optimized rehabilitation systems.

Robot-assisted rehabilitation treadmills are advanced therapy systems that integrate robotic support, sensors, and software to assist patients during gait training. They deliver controlled, repetitive walking movements while adjusting support according to the patient’s abilities. These systems help patients regain mobility, strength, and coordination following neurological or orthopedic injuries, improving rehabilitation outcomes, therapy consistency, and clinical efficiency.

The primary product types of robot-assisted rehabilitation treadmills are end-effector-based treadmills, exoskeleton-based treadmills, gait training treadmills, and others. End-effector-based treadmills are robotic rehabilitation systems that guide patient foot movement to support repetitive gait training and neurological recovery. These systems operate using semi-automated and fully automated technologies, used in neurological rehabilitation, orthopedic rehabilitation, geriatric rehabilitation, and others, among end users including hospitals, rehabilitation centers, clinics, home care settings, and others.

The robot-assisted rehabilitation treadmills market consists of revenues earned by entities by providing services such as robot-assisted gait training services, robotic treadmill therapy sessions, neurorehabilitation support services, post-stroke mobility training services, and assisted physiotherapy rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The robot-assisted rehabilitation treadmills market also includes sales of robot-assisted rehabilitation treadmills, robotic gait training treadmills, body-weight support treadmill systems, robotic exoskeleton-integrated treadmills, and sensor-equipped rehabilitation treadmill units. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.